WASHINGTON, July 21 -- Food and Drug Administration has issued a notice called: Expedited Investigational New Drug Pilot Program; Request for Information; Extension of the Comment Period.
The notice was published in the Federal Register on July 21 by Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs.
Summary: The Food and Drug Administration (FDA or the Agency) is extending the comment period for the notice that appeared in the Federal Registerof June 24, 2026, to open a public docket to solicit input and comments on a proposal to establish a pilot program, the Expedited Investigational New Drug (IND) pilot program, to shorten the time it takes from drug identification to first-in-human (FIH) study, w...